Skip to playerSkip to main content
  • 19 hours ago
Scientists from Swinburne University of Technology are exploring the efficacy of sulforaphane, a natural substance sourced from broccoli, as a possible remedy for Friedreich ataxia, a rare genetic neurological condition. This disorder impairs motor skills, speech, and overall survival as nerve cells deteriorate. Approximately 200 individuals in Australia are diagnosed with Friedreich ataxia, and there is currently no available cure. Laboratory studies indicate that sulforaphane enhances levels of frataxin, a protein that is deficient in affected patients, while also providing protection to at-risk nerve cells. Researchers emphasize the necessity for clinical trials to ascertain whether these results can lead to a viable treatment, especially for pediatric patients.

Disclosure: This video contains stock footage and content created or enhanced using Al-assisted tools.
ai-generated

Category

🗞
News
Transcript
00:00A natural compound found in broccoli is being studied as a potential treatment for a rare
00:04neurological disease. Researchers at Swinburne University of Technology are investigating
00:10sulforaphane and its effects on Friedreich ataxia. Friedreich ataxia is an inherited disorder
00:16that progressively damages nerve cells, affecting movement, speech, and coordination. The disease
00:22is extremely rare, affecting around 200 people in Australia. There is currently no cure,
00:28and researchers say children have particularly limited treatment options. Laboratory research
00:33found that sulforaphane can increase levels of frataxin, a protein deficient in people with
00:38the disease. The compound also appeared to protect vulnerable nerve cells from damage.
00:44Researchers say sulforaphane may influence processes linked to cellular stress and inflammation,
00:49but the findings are still at the research stage and do not yet prove the compound can treat patients.
00:55The next major step is securing funding for clinical trials to test its safety and effectiveness.
01:00If successful, researchers hope the work could lead to a more accessible treatment for families
01:05affected by this rare disease. Disclosure. This video contains stock footage and content created
01:11or enhanced using AI assisted tools.
Comments

Recommended